Diabetic neuropathy
230 results
1 - 100
Diabetic neuropathy - Summary of symptoms and findings for the diagnosis of diabetic neuropathy or painful diabetic neuropathy - Image
Duloxetine decreases pain of diabetic neuropathy- Anticonvulsants for diabetic neuropathy
- Treatments for diabetic neuropathy vary in benefit
Alpha‐lipoic acid for diabetic peripheral neuropathy- Chinese herbal medicine for diabetic peripheral neuropathy
- Enhanced glucose control for preventing and treating diabetic neuropathy
- Cannabis product ineffective for diabetic peripheral neuropathy
- Decompressive surgery of lower limbs for symmetrical diabetic peripheral neuropathy
- Enhanced glucose control for preventing and treating diabetic neuropathy in type 1 diabetes
- Aldose reductase inhibitors for the prevention and treatment of diabetic peripheral neuropathy
- Acetyl‐L‐carnitine for the treatment of diabetic peripheral neuropathy
- High-frequency spinal cord stimulation improves pain in patients with refractory painful diabetic neuropathy
- Omega‐3 fatty acid supplementation for distal symmetrical peripheral neuropathy in adults with diabetes mellitus
- Amitriptyline, duloxetine, and pregabalin each effective in decreasing pain from diabetic peripheral neuropathy; combinations even better
- Anticonvulsants, SNRIs, and rubefacients are best initial choices for chronic pain caused by diabetic neuropathy or postherpetic neuralgia
- Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia: Cochrane systematic review
- Immunotherapy for diabetic amyotrophy
- TCA, capsaicin, older anticonvulsants best for neuropathy
- Regular check-ups of patients with diabetes
- Clinical manifestations of neuropathies that damage large fibres and small fibres - Image
- Treatment of the diabetic foot
- Peripheral neuropathies: examination of the patient
- Long-term adverse effects of antineoplastic agents
- Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia
- Polyneuropathies
- Vitamin B for treating peripheral neuropathy: Cochrane systematic review
- Semaglutide is associated with an increased risk of optic neuropathy
- Erectile dysfunction
- The efficacy of SSRIs in the management of chronic pain